About 6 results found for searched term "FASN-IN-1" (0.119 seconds)
Cat.No. | Name | Target |
---|---|---|
M14433 | FASN-IN-1 | FAS |
FASN-IN-1 is a fatty acid synthase (FASN) inhibitor. | ||
M8622 | TVB-3166 | FAS |
TVB3166 | ||
TVB-3166 is a cell-permeable pyrrazole derivative that inhibits cellular palmitate synthesis (IC50 <100 nM) by fatty acid synthase (FASN) keto-reductase activity in a potent and reversible manner (IC50 = 42 nM), effectively inhibiting palmitate-dependent survival of various cancer cells in cultures and xenografted tumor growth in mice vivo (60-100 mg/kg/d p. | ||
M10175 | TVB-3664 | FAS |
TVB3664 | ||
TVB-3664 is a FASN inhibitor with IC50 values of 18 nM and 12 nM for human and mouse cell palmitate synthesis, respectively. TVB-3664 significantly reduces tubulin palmitoylation and mRNA expression. | ||
M14432 | FASN-IN-4 tosylate | FAS |
FASN-IN-4 tosylate is a potent inhibitor of fatty acid synthase (FASN) with an IC50 of 10 nM (WO2012064642A1, compound 29). FASN-IN-4 tosylate also inhibits SARS-CoV-2 with an EC50 of 18.6 nM. | ||
M28252 | GSK837149A | FAS |
GSK837149A is a selective inhibitor of human Fatty Acid Synthase (FASN) targeting the KR domain. GSK837149A has reversible inhibition effect on FASN and selectivity for type I FASN (Ki=30 nM). GSK837149A is also a competitive inhibitor of NADPH and a non-competitive inhibitor of acetoacetyl-CoA. GSK837149A can be used for the research of obesity and breast cancer. | ||
M56691 | Fasnall | FAS |
Fasnall is a selective fatty acid synthase (FASN) inhibitor with an IC50 of 3.71 μM. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.